Facility Evaluation Report

On 06/26/2023, Licensing Program Analysts (LPAs) Arielle Pascua and Christina Valerio arrived unannounced to conduct a complaint visit. LPAs were greeted by Staff Member (SM) Andrea Rush and explained the purpose of the visit. LPA Pascua asked that SM Rush call the Facility Designated Administrator (FDA) and inform them that CCL was present at this time. LPA Pascua learned that FDA, Julian Hawes, was unable to make it to the facility at this time. LPAs continued the visit with SM Rush. The purpose of this visit was to deliver complaint findings for the allegations above.

The purpose of this visit was to provide the facility a copy of a Non-Compliance Letter informing the Licensee that a meeting will take place on Wednesday, 06/28/2023. A previous letter was sent out via certified mail on 06/09/2023.

An exit interview was held, and a copy of the report was provided.